Hammertoe

Duration
85 days
Ages
18 to 75
Trial Setting
Outpatient
Compensation
Information coming soon

A phase 3, double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of (trade secret) vs placebo in the treatment of flexible/semi-flexible hammertoe (HMT).

Criteria:

  • Hammertoe in at least one toe, other than big toe and pinkie toe
  • Hammertoe is flexible or semi-flexible